Therapeutic implication of oxidative stress-induced growth inhibitor 1 (OSGIN1) in cancer

Area of Science:

• Biochemistry and Molecular Biology
• Cellular Biology
• Oncology

Background:

• Oxidative stress, an imbalance of free radicals and antioxidants, influences cellular functions and pathogenesis.
• While biomarkers for oxidative stress are advancing, clinical validation for diagnostics and therapeutics is crucial.
• Understanding the molecular mechanisms and clinical significance of oxidative stress response proteins is increasingly important.

Purpose of the Study:

• To review the role of oxidative stress-induced growth inhibitor 1 (OSGIN1) in tumorigenesis.
• To highlight OSGIN1's cellular functions, isoform expression, and regulatory signaling pathways, particularly in cancer.
• To provide an overview of OSGIN1's clinical significance and molecular mechanisms.

Main Methods:

• Literature review of existing research on OSGIN1.
• Analysis of cellular processes and functions related to OSGIN1 expression.
• Examination of signaling pathways regulating OSGIN1 in cancer.

Main Results:

• OSGIN1 is an oxidative stress response protein with implicated roles in chronic diseases and cancers.
• The functions and roles of OSGIN1 in tumorigenesis require further appreciation.
• OSGIN1 expression is regulated by various cellular signaling pathways, with implications for cancer development.

Conclusions:

• OSGIN1 plays a significant role in cellular responses to oxidative stress.
• Further research into OSGIN1's molecular mechanisms and clinical applications, especially in oncology, is warranted.
• Understanding OSGIN1's regulation and function is key to developing new diagnostic and therapeutic strategies for oxidative stress-related diseases.